Equity - Narrative (Details)
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
Oct. 25, 2021
USD ($)
|
Aug. 06, 2020
USD ($)
|
Jul. 28, 2020
USD ($)
|
Jun. 11, 2020
USD ($)
$ / shares
shares
|
Dec. 18, 2019
USD ($)
$ / shares
shares
|
Jun. 27, 2017
USD ($)
$ / shares
shares
|
Aug. 31, 2017
USD ($)
|
Mar. 31, 2021
USD ($)
shares
|
Mar. 31, 2020
USD ($)
|
Dec. 31, 2021
USD ($)
vote
$ / shares
shares
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2019
USD ($)
$ / shares
shares
|
Aug. 31, 2020
$ / shares
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock through at-the-market offering, net | $ |
|
|
|
|
|
|
|
|
|
$ 51,934,000
|
$ 2,108,000
|
$ 1,006,000
|
|
| Class of warrant or right, outstanding (in shares) |
|
|
|
|
|
|
|
|
|
10,735,980
|
12,378,016
|
31,426,248
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 1.62
|
$ 1.60
|
$ 1.12
|
$ 2.54
|
| Warrant liabilities | $ |
|
|
|
|
|
|
|
|
|
$ 25,423,000
|
$ 28,708,000
|
|
|
| Common stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
200,000,000
|
200,000,000
|
|
|
| Common stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
| Common stock, shares issued (in shares) |
|
|
|
|
|
|
|
|
|
123,622,965
|
108,071,249
|
|
|
| Common stock, shares outstanding (in shares) |
|
|
|
|
|
|
|
|
|
123,622,965
|
108,071,249
|
|
|
| Number of votes per share that common stockholders are entitled to | vote |
|
|
|
|
|
|
|
|
|
1
|
|
|
|
| Dividends declared or paid on common stock | $ |
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, outstanding (in shares) |
|
|
|
|
|
|
|
|
|
10,443,511
|
12,085,547
|
22,988,501
|
|
| Class of warrant or right, number of warrants exercised (in shares) |
|
|
|
|
|
|
|
|
|
1,642,036
|
|
|
|
| Issuance of common stock upon exercise of common warrants (in shares) |
|
|
|
|
|
|
|
|
|
1,076,669
|
|
|
|
| At-The-Market Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale common stock | $ |
$ 75,000,000.0
|
|
|
|
|
|
$ 50,000,000.0
|
|
|
|
|
|
|
| Sale of stock, number of shares issued in transaction (in shares) |
|
|
|
|
|
|
|
1,069,486
|
|
13,767,511
|
|
|
|
| Net proceeds from issuance of common stock | $ |
|
|
|
|
|
|
|
$ 2,100,000
|
|
$ 51,900,000
|
|
|
|
| Net proceeds from issuance of common stock | $ |
|
|
|
|
|
|
|
|
|
51,958,000
|
$ 2,108,000
|
$ 1,006,000
|
|
| August 2020 Shelf Registration Statement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale common stock | $ |
|
$ 200,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| SOBI Purchase Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale common stock | $ |
|
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
| Sale of stock, number of shares issued in transaction (in shares) |
|
|
|
5,416,390
|
|
|
|
|
|
|
|
|
|
| Share price (in dollars per share) | $ / shares |
|
|
|
$ 4.6156
|
|
|
|
|
|
|
|
|
|
| Sale of stock, percentage of ten-day volume weighted average price of common stock |
|
|
|
120.00%
|
|
|
|
|
|
|
|
|
|
| Redemption premium | $ |
|
|
$ 14,500,000
|
|
|
|
|
|
|
|
|
|
|
| December 2019 Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale common stock | $ |
|
|
|
|
$ 65,600,000
|
|
|
|
|
|
|
|
|
| Sale of stock, number of shares issued in transaction (in shares) |
|
|
|
|
37,634,883
|
|
|
|
|
|
|
|
|
| Share price (in dollars per share) | $ / shares |
|
|
|
|
$ 1.46
|
|
|
|
|
|
|
|
|
| Class of warrant or right, outstanding (in shares) |
|
|
|
|
22,988,501
|
|
|
|
|
|
|
|
|
| Warrant issued | $ |
|
|
|
|
$ 40,700,000
|
|
|
|
|
|
|
|
|
| Issuance costs | $ |
|
|
|
|
|
|
|
|
$ 4,400,000
|
|
|
|
|
| Warrant liabilities | $ |
|
|
|
|
|
|
|
|
|
25,400,000
|
|
|
|
| Warrant, decrease in equity, amount | $ |
|
|
|
|
|
|
|
|
|
$ (2,300,000)
|
$ (10,400,000)
|
$ (900,000)
|
|
| December 2019 Financing | Pre-Funded Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of warrants exercised (in shares) |
|
|
|
|
8,342,128
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
| December 2019 Financing | Common Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price (in dollars per share) | $ / shares |
|
|
|
|
0.125
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
$ 1.46
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding, term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
| 2017 PIPE |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, number of shares issued in transaction (in shares) |
|
|
|
|
|
2,750,000
|
|
|
|
|
|
|
|
| Share price (in dollars per share) | $ / shares |
|
|
|
|
|
$ 16.00
|
|
|
|
|
|
|
|
| Net proceeds from issuance of common stock | $ |
|
|
|
|
|
$ 47,100,000
|
|
|
|
|
|
|
|
| Common stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
200,000,000
|
|
|
|
| Common stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
| Springer Purchase Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price (in dollars per share) | $ / shares |
|
|
|
|
|
$ 17.71
|
|
|
|
|
|
|
|
| Springer Purchase Agreement | Common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, net of issuance costs (in shares) |
|
|
|
|
|
338,791
|
|
|
|
|
|
|
|
| Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, number of shares issued in transaction (in shares) |
|
|
|
|
|
79,130
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
$ 17.71
|
|
|
|
|
|
|
|
| Warrants and rights outstanding, term |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
| Share price (in dollars per share) | $ / shares |
|
|
|
|
|
$ 0.125
|
|
|
|
|
|
|
|